Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children; nursing services in school settings in which our caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; unskilled nursing services; and employer of record support services, as well as in-clinic and home-based pediatric therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers a line of durable medical equipment and enteral nutrition supplies to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
IPO Year: 2021
Exchange: NASDAQ
Website: aveanna.com
Date | Price Target | Rating | Analyst |
---|---|---|---|
12/13/2023 | Neutral → Underweight | JP Morgan | |
11/30/2023 | $1.50 | Sell | UBS |
5/12/2023 | Strong Buy → Mkt Perform | Raymond James | |
1/27/2023 | $2.00 → $1.00 | Neutral → Underperform | Credit Suisse |
11/21/2022 | $7.00 → $3.00 | Outperform → Sector Perform | RBC Capital Mkts |
11/17/2022 | $5.50 → $2.00 | Outperform → Neutral | Credit Suisse |
7/22/2022 | $2.50 | Buy → Hold | Jefferies |
7/5/2022 | Buy → Hold | Truist | |
6/21/2022 | $3.00 → $2.00 | Neutral → Underperform | BofA Securities |
6/21/2022 | $5.50 → $3.50 | Overweight → Equal-Weight | Stephens |
4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)
3 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)
4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)
4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)
4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)
4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)
4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)
4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)
4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)
4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)
SC 13G - Aveanna Healthcare Holdings, Inc. (0001832332) (Subject)
SC 13G - Aveanna Healthcare Holdings, Inc. (0001832332) (Subject)
S-3/A - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)
S-3 - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)
8-K - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)
8-K - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)
10-Q - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)
8-K - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)
8-K - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)
8-K - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)
8-K - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)
10-Q - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)
ATLANTA, April 03, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Jerry Perchik to serve as Chief Legal Officer and Secretary, effective April 29, 2024. "I am pleased to announce the appointment of Jerry to the Chief Legal Officer and Secretary role. Jerry has a strong background in corporate law and a wealth of healthcare industry and regulatory experience. I have known Jerry for more than a decade and have great trust in his leadership and counsel. It is a pleasure to welcome Jerry to our Aveanna family, and
ATLANTA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Matt Buckhalter to serve as Chief Financial Officer and continuing in the role of Principal Financial Officer, effective January 1, 2024. Mr. Buckhalter was appointed to serve as Interim Chief Financial Officer and Principal Financial Officer in July, 2023. "I am pleased to announce the promotion of Matt to the Chief Financial Officer position. Matt has provided strong financial leadership and continuity as we build on our recent successes to t
ATLANTA, June 15, 2023 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that David Afshar has resigned from his position as Chief Financial Officer, Principal Accounting Officer and Principal Financial Officer effective July 7, 2023, to pursue other opportunities, and not due to any disagreement with Aveanna's management, operations, policies or practices, including financial matters. "On behalf of the entire Aveanna team, I'd like to thank Dave for his contributions over the last five years. Since joining the Company in February 2018, Dave has been instrumental in building and strengthening our finance team and successfully leading our transi
ATLANTA, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings, Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced that its Chief Executive Officer and Director, Tony Strange, is retiring and will depart the company effective December 31, 2022. Jeff S. Shaner, Aveanna's long serving Chief Operations Officer, will serve as CEO and Director, effective December 31, 2022. "Tony's leadership was a significant part of Aveanna's formation and growth since its inception five years ago. He leaves an enduring legacy of building one of the nation's largest home care companies in America,
Dr. Erica Schwartz joins Butterfly's Board of Directors Troy Quander joins Butterfly as Senior Vice President, Regulatory and Quality Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), an innovative digital health company that is working to democratize medical imaging and contribute to the aspiration of global health equity, today announced the expansion of its Board of Directors to nine directors through the appointment of Dr. Erica Schwartz and the addition of Troy Quander to the leadership team as Senior Vice President, Regulatory and Quality. These appointments continue to strengthen the technical foundation of the company to ensure that it can effectively execute its mission of dem
ATLANTA, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that its management team will attend the Deutsche Bank Annual Leveraged Finance Conference in Scottsdale, AZ on September 24, 2024. Management will host 1x1 investor meetings that day. About Aveanna HealthcareAveanna Healthcare is headquartered in Atlanta, Georgia and has locations in 33 states providing a broad range of pediatric and adult healthcare services including nursing, rehabilitation services, occupational nursing in schools, therapy services, day treatment centers for medically fragile and chronically ill children and adults, home health and hospice services, a
Second Quarter Revenue was $505.0 million, a 7.0% increase over the prior year Gross margin increased 1.9% to $158.3 million, compared to Q2 2023 Second Quarter Net income was $13.9 million, compared to net income of $25.6 million in the comparable prior year period Adjusted Net income was $2.5 million, an increase of $6.6 million over the comparable prior year period Adjusted EBITDA was $45.6 million, a 27.3% increase as compared to the prior year periodFull Year 2024 Revenue guidance raised to greater than $1,985 million Full Year 2024 Adjusted EBITDA guidance raised to greater than $158 million ATLANTA, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDA
ATLANTA, July 18, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that the company will release its second quarter results before the market open on Thursday, August 8, 2024, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13746737. The replay will be available until August 15, 2024. Int
ATLANTA, May 20, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that its management team will attend the UBS Healthcare Services Cape Cod Summit in Chatham, MA on Tuesday, June 4, 2024, and the Jefferies Global Healthcare Conference in New York on Wednesday, June 5, 2024. Management will host 1x1 investor meetings at the UBS Healthcare Services Summit on June 4, 2024. For the Jefferies Global Healthcare Conference on June 5, 2024, management will host 1x1 investor meetings as well as a fireside chat at 3:30pm Eastern Time. Interested investors and other parties may also listen to a simultaneous webcast of the fireside chat by logging on
First Quarter Revenue was $490.7 million, a 5.2% increase over the prior year Gross margin increased 1.0% to $145.9 million, compared to Q1 2023 First Quarter Net loss was $11.2 million, compared to net loss of $32.0 million in the comparable prior year period Adjusted EBITDA was $34.9 million, a 22.5% increase as compared to the prior year quarter Full Year 2024 Revenue guidance raised to greater than $1,970 million Full Year 2024 Adjusted EBITDA guidance raised to greater than $150 million ATLANTA, May 09, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient
ATLANTA, May 03, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that its management team will attend the Barclays Leveraged Finance Conference in Austin, TX on May 21, 2024. Management will host 1x1 investor meetings that day. About Aveanna Healthcare Aveanna Healthcare is headquartered in Atlanta, Georgia and has locations in 33 states providing a broad range of pediatric and adult healthcare services including nursing, rehabilitation services, occupational nursing in schools, therapy services, day treatment centers for medically fragile and chronically ill children and adults, home health and hospice services, as well as delivery of
ATLANTA, May 01, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that its management team will attend the RBC Capital Markets Global Healthcare Conference in New York on May 14, 2024. Management will host 1x1 investor meetings as well as a fireside chat at 10:30 a.m. Eastern Time on the same day, May 14, 2024. Interested investors and other parties may also listen to a simultaneous webcast of the fireside chat by logging onto the Investor Relations section of the Company's website at https://ir.aveanna.com/. The online replay will be available for a limited time shortly following the call. About Aveanna Healthcare Aveanna Healthcare is
ATLANTA, April 18, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that the company will release its first quarter results before the market open on Thursday, May 9, 2024, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13745298. The replay will be available until May 16, 2024. Interest
ATLANTA, April 03, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Jerry Perchik to serve as Chief Legal Officer and Secretary, effective April 29, 2024. "I am pleased to announce the appointment of Jerry to the Chief Legal Officer and Secretary role. Jerry has a strong background in corporate law and a wealth of healthcare industry and regulatory experience. I have known Jerry for more than a decade and have great trust in his leadership and counsel. It is a pleasure to welcome Jerry to our Aveanna family, and
Fourth Quarter Revenue was $478.8 million, a 6.1% increase over the prior year Gross margin increased 15.3% to $148.4 million, compared to Q4 2022 Fourth Quarter Net loss was $25.7 million, compared to net loss of $237.8 million in the comparable prior year period Adjusted EBITDA was $38.7 million, a 30.4% increase as compared to the prior year quarter Expect Full Year 2024 Revenue between $1,960 million and $1,980 million and Adjusted EBITDA between $146 million and $150 million ATLANTA, March 14, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient
Shares of CrowdStrike Holdings, Inc. (NASDAQ:CRWD) fell sharply during Monday’s session. Guggenheim analyst John Difucci downgraded the stock from Buy to Neutral, while BTIG analyst Gray Powell downgraded the stock from Buy to Neutral. CrowdStrike shares dipped over 11% on Friday after the company suffered a major outage impacting businesses around the world. Selective Insurance Group shares dipped 13.2% to $264.65 on Friday. Here are some other stocks moving in today’s mid-day session. Gainers MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) shares climbed 148% to $1.98 after the company announced new preclinical study results for its novel oral ketamine analog, Ketamir-2. CareMa
U.S. stocks were higher, with the Nasdaq Composite gaining over 100 points on Monday. Shares of IQVIA Holdings Inc. (NYSE:IQV) rose sharply during Monday's session after the company released better-than-expected second-quarter financial results and raised its 2024 guidance. IQVIA reported a second adjusted EPS of $2.64, up from $2.43, beating the consensus of $2.57. Provider of advanced analytics reported sales of $3.81 billion, beating the consensus of $3.79 billion, according to data from Benzinga Pro. IQVIA Holdings shares jumped 7.4% to $241.07 on Monday. Here are some other big stocks recording gains in today’s session. Tellurian Inc. (NASDAQ:TELL) shares surged 64.5% to
As of July 16, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro. Here's the latest list of major overbought players in this sector. Aveanna Healthcare Holdings Inc (NASDAQ:AVAH) On May 9, Aveanna Healthcare posted a narrowe
djusted EBITDA of greater than $150 million, updated from prior guidance of Adjusted EBITDA between $146 million and $150 million
Aveanna Healthcare Hldgs (NASDAQ:AVAH) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.05) by 40 percent. This is a 40 percent increase over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $490.653 million which beat the analyst consensus estimate of $483.976 million by 1.38 percent. This is a 5.20 percent increase over sales of $466.413 million the same period last year.
Deutsche Bank analyst Pito Chickering maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Buy and raises the price target from $2 to $3.
Aveanna Healthcare Hldgs (NASDAQ:AVAH) reported adjusted quarterly losses of $(0.02) per share which met the analyst consensus estimate. This is a 33.33 percent increase over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $478.84 million which beat the analyst consensus estimate of $467.40 million by 2.45 percent. This is a 6.14 percent increase over sales of $451.15 million the same period last year.
Second Quarter Revenue was $505.0 million, a 7.0% increase over the prior year Gross margin increased 1.9% to $158.3 million, compared to Q2 2023 Second Quarter Net income was $13.9 million, compared to net income of $25.6 million in the comparable prior year period Adjusted Net income was $2.5 million, an increase of $6.6 million over the comparable prior year period Adjusted EBITDA was $45.6 million, a 27.3% increase as compared to the prior year periodFull Year 2024 Revenue guidance raised to greater than $1,985 million Full Year 2024 Adjusted EBITDA guidance raised to greater than $158 million ATLANTA, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDA
ATLANTA, July 18, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that the company will release its second quarter results before the market open on Thursday, August 8, 2024, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13746737. The replay will be available until August 15, 2024. Int
First Quarter Revenue was $490.7 million, a 5.2% increase over the prior year Gross margin increased 1.0% to $145.9 million, compared to Q1 2023 First Quarter Net loss was $11.2 million, compared to net loss of $32.0 million in the comparable prior year period Adjusted EBITDA was $34.9 million, a 22.5% increase as compared to the prior year quarter Full Year 2024 Revenue guidance raised to greater than $1,970 million Full Year 2024 Adjusted EBITDA guidance raised to greater than $150 million ATLANTA, May 09, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient
ATLANTA, April 18, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that the company will release its first quarter results before the market open on Thursday, May 9, 2024, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13745298. The replay will be available until May 16, 2024. Interest
Fourth Quarter Revenue was $478.8 million, a 6.1% increase over the prior year Gross margin increased 15.3% to $148.4 million, compared to Q4 2022 Fourth Quarter Net loss was $25.7 million, compared to net loss of $237.8 million in the comparable prior year period Adjusted EBITDA was $38.7 million, a 30.4% increase as compared to the prior year quarter Expect Full Year 2024 Revenue between $1,960 million and $1,980 million and Adjusted EBITDA between $146 million and $150 million ATLANTA, March 14, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient
ATLANTA, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that the company will release its fourth quarter and full year results before the market open on Thursday, March 14, 2024, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13743056. The replay will be available until March 2
Revenue was $478.0 million, a 7.9% increase over the prior year Gross margin increased 9.4% to $147.3 million, compared to Q3 2022 Net loss was $102.4 million, inclusive of a $105.1 million non-cash goodwill impairment, compared to net income of $24.3 million in the comparable prior year period Adjusted EBITDA was $36.2 million, a 46.2% increase as compared to the prior year Full year 2023 revenue guidance raised to a range of $1,870 million to $1,880 million Full year 2023 Adjusted EBITDA guidance raised to a range of $134 million to $137 million ATLANTA, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused o
ATLANTA, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that the company will release its third quarter results before the market open on Thursday, November 9, 2023, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13740762. The replay will be available until November 16, 2023.
Revenue was $471.9 million, a 6.5% increase over the prior year Gross margin increased 7.0% to $155.3 million, compared to Q2 2022 Net income was $25.6 million, compared to net loss of $473.9 million in the comparable prior year period Adjusted EBITDA was $35.8 million, a sequential increase of 25.6% and a 3.2% decrease as compared to the prior year Full year 2023 revenue guidance raised to a range of $1,850 million to $1,860 million Full year 2023 Adjusted EBITDA guidance raised to a range of $132 million to $135 million ATLANTA, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medica
ATLANTA, July 20, 2023 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that the company will release its second quarter results before the market open on Thursday, August 10, 2023, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13738992. The replay will be available until August 17, 2023. In
JP Morgan downgraded Aveanna from Neutral to Underweight
UBS initiated coverage of Aveanna with a rating of Sell and set a new price target of $1.50
Raymond James downgraded Aveanna from Strong Buy to Mkt Perform
Credit Suisse downgraded Aveanna from Neutral to Underperform and set a new price target of $1.00 from $2.00 previously
RBC Capital Mkts downgraded Aveanna from Outperform to Sector Perform and set a new price target of $3.00 from $7.00 previously
Credit Suisse downgraded Aveanna from Outperform to Neutral and set a new price target of $2.00 from $5.50 previously
Jefferies downgraded Aveanna from Buy to Hold and set a new price target of $2.50
Truist downgraded Aveanna from Buy to Hold
BofA Securities downgraded Aveanna from Neutral to Underperform and set a new price target of $2.00 from $3.00 previously
Stephens downgraded Aveanna from Overweight to Equal-Weight and set a new price target of $3.50 from $5.50 previously